Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical ...

Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced a strategic collaboration with Novartis to discover and develop in ...

Diamond-Blackfan anemia (DBA) is a rare, life-threatening genetic blood disorder. It impairs the bone marrow's ability to ...

Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial and operational ...

As data complexity continues to rise, enterprises find it crucial to establish multimodal pipelines and manage vector databases at a production scale. In a recent discussion with AIM, Chetan Dixit, ...

Airbus is maintaining its full-year delivery estimate and its longer-term production ramp-up targets, although it states that supply-chain issues remain a concern. The airframer says it is ...

Russia’s Nornickel, the world’s largest producer of palladium and a major producer of refined nickel, has raised its 2024 production guidance for all metals. The company said on Monday that ...

Vector manufacturing platform, LentiSure for increasing lentivirus production robustness and efficiency. Lentivirus is used to produce cell-based immune-oncology therapies. Europe Viral Vector And ...

As the plastics treaty heads toward the finish line, the debate over limits or caps on virgin resin production has gotten louder, with the Biden administration and now some global businesses ...

No major functional disabilities were observed at month 24; 81% of patients had no major functional disabilities at median of 6 years. HealthDay News — For boys with early-stage cerebral ...